Disease/Infection News

RSS

Researchers report the exceptional binding and neutralizing potency of an ACE2 decoy against SARS-CoV-2 variants

Researchers explored the activity of an ACE2 decoy against SARS-CoV-2 Omicron variant.

30 Aug 2022

Exploration of glycan shield structure of sarbecoviruses provides new insights into developing pan-coronavirus vaccines

A new study explored the glycan shield diversity of sarbecoviruses, furthering the knowledge for developing broad-range pan-coronavirus vaccines.

30 Aug 2022

Researchers find evidence of negative repercussions of immune history in SARS-CoV-2 infection

Researchers found proof of negative repercussions of immune history in SARS-CoV-2 infection.

30 Aug 2022

Risk factors among pregnant and postpartum women with COVID-19

Researchers investigated the clinical risk factors associated with adverse outcomes among COVID-19-infected women during pregnancy and postpartum.

30 Aug 2022

Study finds strong evidence for the ability of SARS-CoV-2 to infect human sperm in vitro

Researchers explored the molecular and cellular mechanisms of SARS-CoV-2 infection.

30 Aug 2022

mRNA COVID boosters are effective against severe Omicron for at least six months

A new study published in the journal JAMA Network Open aimed to analyze the association of the types of vaccine and their combination with the waning of protection against Omicron in residents of Singapore who were aged 30 years and above and had received at least two doses of a COVID vaccine.

30 Aug 2022

Men who have sex with men adopting protective measures against monkeypox virus

The U.S. Centers for Disease Control and Prevention (CDC) recently published the results of a survey specific to monkeypox virus (MPV) infection associated with the American Men's Internet Survey (AMIS) in the Morbidity and Mortality Weekly Report (MMWR).

29 Aug 2022

Gay, and bisexual men changing sexual behavior to reduce risk of monkeypox

A study conducted by scientists from the US Centers for Disease Control and Prevention (CDC) indicates that reducing one-time sexual partnerships among gay, bisexual, and other men who have sex with men can significantly reduce the transmission of the monkeypox virus.

29 Aug 2022

Monkeypox virus detected on household items

The CDC study describes how the monkeypox virus spreads on household surfaces.

29 Aug 2022

IBS discussed collaboration with NIAID and St. Jude’s Children’s Research Hospital

The Institute for Basic Science recently visited the National Institutes of Health and announced its collaboration with St. Jude Children's Research Hospital in the U.S., with the aims of increasing virus research capacity and ability to respond to infectious disease outbreaks.

29 Aug 2022

Post-acute sequelae of SARS-CoV-2 infection in children appears to be lower than in adults

A new study conducted by the National Institutes of Health (NIH) RECOVER Pediatric Electronic Health Records (EHR) Cohort and authored by Suchitra Rao, MD, infectious disease specialist at Children's Hospital Colorado, found that the risk of post-acute sequelae of SARS-CoV-2 infection (PASC), or long COVID, in children appears to be lower than what has been reported in adults.

29 Aug 2022

SARS-CoV-2 antigen levels associated with COVID-19 severity and other clinical outcomes

The amount of SARS-CoV-2 antigen measured in the blood of patients hospitalized with COVID-19 is associated with illness severity and other clinical outcomes, according to a new study published in the Annals of Internal Medicine.

29 Aug 2022

Full-dose anticoagulation lowers the risk of blood clotting complications in COVID-19 patients

A clinical trial of patients with COVID-19 led by investigators at the TIMI Study Group at Brigham and Women's Hospital and the Critical Care Cardiology Trials Network has found that full-dose anticoagulation lowers the risk of blood clotting complications compared with standard-dose prophylactic anticoagulation.

29 Aug 2022

Herpesvirus-6 and Epstein–Barr virus reactivation across acute SARS-CoV-2 patients

In a new story, scientists explored human herpesvirus-6 (HHV-6) and Epstein–Barr virus (EBV) reactivation among acute coronavirus disease 2019 (COVID-19) patients.

29 Aug 2022

Study identifies two potential serological biomarkers of monkeypox infection

In a new study, researchers pursued two monkeypox virus (MPXV) immune targets, A35R and H3L, that could be deployed in a serological assay to identify recent MPXV cases.

29 Aug 2022

The clinical and virological outcomes associated with molnupiravir or nirmatrelvir–ritonavir use in hospitalized patients with mild-to-moderate COVID-19

Researchers investigated whether early treatment with oral antivirals prevented all-cause mortality in hospitalized patients infected with SARS-CoV-2 new variant of concern Omicron BA.2 subvariant.

29 Aug 2022

Disease/Infection News

Researchers report the exceptional binding and neutralizing potency of an ACE2 decoy against SARS-CoV-2 variants

Exploration of glycan shield structure of sarbecoviruses provides new insights into developing pan-coronavirus vaccines

Researchers find evidence of negative repercussions of immune history in SARS-CoV-2 infection

Risk factors among pregnant and postpartum women with COVID-19

Study finds strong evidence for the ability of SARS-CoV-2 to infect human sperm in vitro

mRNA COVID boosters are effective against severe Omicron for at least six months

Men who have sex with men adopting protective measures against monkeypox virus

Gay, and bisexual men changing sexual behavior to reduce risk of monkeypox

Monkeypox virus detected on household items

IBS discussed collaboration with NIAID and St. Jude’s Children’s Research Hospital

Post-acute sequelae of SARS-CoV-2 infection in children appears to be lower than in adults

SARS-CoV-2 antigen levels associated with COVID-19 severity and other clinical outcomes

Full-dose anticoagulation lowers the risk of blood clotting complications in COVID-19 patients

Herpesvirus-6 and Epstein–Barr virus reactivation across acute SARS-CoV-2 patients

Study identifies two potential serological biomarkers of monkeypox infection

The clinical and virological outcomes associated with molnupiravir or nirmatrelvir–ritonavir use in hospitalized patients with mild-to-moderate COVID-19

Review of the risks and benefits of statins in primary prevention of cardiovascular diseases in adults

Protection against SARS-CoV-2 reinfections in the Qatari population

The effectiveness of nirmatrelvir in preventing severe COVID-19 outcomes during the Omicron surge

Is there an association between the gut microbiome of people within different countries and the severity of COVID-19?

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News